1Sullivan KM, Shulman HM,Storb R. Chronic graft versus host disease in 52 patients:adverse natural course and successful treatment with combination immunosuppression[J]. Blood,1981, 7:267 -276
2Atkinson K,Bryant D,Delprado W, et al. Widerspread pulmonary fibrosis as a major clinical manifestation of chronic graft versus host disease[J]. Bone Marrow Transplant, 1989, 4:129 - 132
3Ratanatharathron Ⅴ, Nash RA, Prezepiorka D, et al. Phase Ⅲ syudy comparing methorexate and tacrolimus( prograf, FK506 ) with methotrexate and cylcosporine for graft verus host disease prophylaxi after HLA identical sibling bone marrow transplantation[J]
4Chao NJ, Peter PM, Niland JC, et al. Paradoxical effect of thalidomide prophylaxison chronic graft vs host disease[J]. Biol Blood Marrow Transplant, 1996, 2:86 -92
5Jagasia MH,Greinix HT,Arora MA,et al.National institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-Host disease:I.the 2014 diagnosis and staging working group report[J].Biol Blood Marrow Transplant,2015,21(3):389-401.
6Inamoto Y,Storer BE,Petersdorf EW,et al,Incidence,risk factors,and outcomes of sclerosis in patients with chronic grafl-versus-host disease[J].Blood,2013,121(25):5098-103.
